Strategic Partnerships In The Pharmaceutical Industry Amidst Covid-19 Pandemic

Abstract

The purpose of this research paper is to look into the effect of Coronavirus disease (COVID-19) on the global pharmaceutical industry's ability to build and form strategic partnerships. The study used a descriptive and analytical approach to address the many facets of the subject, using periodic statistics reports. The findings revealed that the COVID-19 pandemic sparked an unprecedented level of partnerships among pharmaceutical companies eager to accelerate the development of vaccines or therapeutics to combat the virus